Sandesh Seth
Chief Executive Officer at Actinium Pharmaceuticals Inc. (Delaware)
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Actinium Pharmaceuticals Inc. (Delaware), 2 years.
Actinium Pharmaceuticals Inc. (Delaware)
Director · Chief Executive Officer
Chief executive roles
Actinium Pharmaceuticals Inc. (Delaware)
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Actinium Pharmaceuticals Inc. (Delaware) | Grant or award | +753,600 | — | — |
| Sep 2, 2026 | Actinium Pharmaceuticals Inc. (Delaware) | Grant or award | +1,027,274 | — | — |
| Aug 18, 2025 | Actinium Pharmaceuticals Inc. (Delaware) | Shares withheld for tax | −120,900 | $1.71 | $206,739 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.